Recent Updates
Recently added Catalysts
BBIO Positive Sentiment Score: 60/100

BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference

Thursday, April 27, 2023 1 min read
Key Takeaway: PALO ALTO, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that members of its management team will present at th

Market Sentiment Analysis

POSITIVE FACTORS

  • BridgeBio Pharma is actively participating in a significant healthcare conference.
  • The event provides an opportunity for the company to showcase its focus on genetic diseases and cancers.
  • Management team's presentation may enhance visibility among investors.

Full Press Release Details

PALO ALTO, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that members of its management team will present at the Bank of America Merrill Lynch Global Healthcare Conference in Las Vegas, NV on Wednesday, May 10 at 10:00 am PT.
To access the live webcast of BridgeBio’s presentation, please visit the “Events & Presentations” page within the Investors section of the BridgeBio website at http://investor.bridgebio.com. A replay of the webcast will be available on the BridgeBio website for 90 days following the event.
About BridgeBio Pharma, Inc.
contact@bridgebio.com

Frequently Asked Questions

When is BridgeBio's presentation at the conference?

BridgeBio will present on May 10 at 10:00 am PT.

Where can I watch the live webcast of the presentation?

The live webcast can be accessed on BridgeBio's website under 'Events & Presentations.'

How long will the recording of the webcast be available?

The replay of the webcast will be available for 90 days after the event.

Who can I contact for more information about BridgeBio?

You can contact Vikram Bali at contact@bridgebio.com or call (650)-789-8220.

Tags: BBIO Viatris Investor Conferences Healthcare BridgeBio bank of america healthcare conference genetic diseases biopharmaceuticals
Last updated: Apr 27, 2023